Tags » Sny

So long for now, New York

Yesterday, my sister Liza, my mother and I drove up to Boston.  It’s amazing how quickly the summer flew by.  I have visited new places in the city.  257 more words


PHOTO GALLERY and VIDEOS: Damien Woody makes Final Citi Kids Program a Touchdown

Former New York Jets offensive lineman and two-time Super Bowl Champion Damien Woody was at Citi Field today to inspire 140 children from United Neighborhood Houses as a part of the Citi Kids program. 232 more words

New York Sports

Have Analysts Fully Priced in Praluent to Regeneron?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein (LDL) cholesterol. 253 more words

Healthcare Business

Moje sny

Nikdy, nikdy v životě by mě nenapadlo, že někdy budu psát článek s takovýmhle názvem. Já, holka z města, která trávila tři dny v týdnu na párty, obličej pomazaný různými barvami, koktejl v ruce, uplé tričko a minisukně,… Ach jo, kde jsou ty časy? 222 more words

Dobrá Nálada

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback. 330 more words

Healthcare Business

Allah svedčí v prospech Ahmada Al Hassána (pmsn)

Allah, Oslavovaný, Všemohúci, svedčí v prospech tých, ktorí svedčia v prospech Imáma Ahmad Al-Hassána (pmsn) skrze sny/vízie, skrze Istikharu a prostredníctvom iných spôsobov neviditeľného, pretože spôsobov Allaha, Oslavovaného, Všemohúceho je (tak veľa), koľko je osobností v stvorení. 1,965 more words


New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. This covers a new class of drugs in the PCSK9 classification, and FDA panels are evaluating more than just one drug candidate. 522 more words

Healthcare Business